» Articles » PMID: 38274971

Hemolytic Disease of the Fetus and Newborn Due to Minor Blood Group Alloimmunization in a Mother of Sickle Cell Disease with Multiple Alloantibodies

Overview
Specialty Hematology
Date 2024 Jan 26
PMID 38274971
Authors
Affiliations
Soon will be listed here.
Abstract

Hemolytic disease of the fetus and newborn is due to maternal IgG antibodies that transport through the placenta and destroy neonatal red cells. A mismatch of antigens between mother and fetus causes isoimmunization resulting in mild anemia, which may progress to fetal hydrops in the intrauterine period and severe hyperbilirubinemia to kernicterus in neonates. The isoimmunization is mainly caused by Rh-D and ABO antibodies. In this case report, we found neonatal hyperbilirubinemia due to the presence of anti-c alloantibody previously developed in a sickle cell disease (SCD) pregnant female. It is an unusual case of fetal hyperbilirubinemia due to minor blood group alloimmunization in a SCD needing exchange transfusion. Multi-transfused patients should be counseled regarding the need to perform antibody screening frequently before pregnancy for better treatment of both mother and child.

Citing Articles

Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes.

Alan S, Sharma D, Pecker L Curr Opin Hematol. 2024; 31(6):285-293.

PMID: 39177058 PMC: 11427169. DOI: 10.1097/MOH.0000000000000837.

References
1.
Yazdanbakhsh K, Ware R, Noizat-Pirenne F . Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012; 120(3):528-37. PMC: 3401213. DOI: 10.1182/blood-2011-11-327361. View

2.
Moise K . Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med. 2008; 13(4):207-14. DOI: 10.1016/j.siny.2008.02.007. View

3.
Pirenne F, Yazdanbakhsh K . How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood. 2018; 131(25):2773-2781. PMC: 6014354. DOI: 10.1182/blood-2018-02-785964. View

4.
Pahuja S, Gupta S, Pujani M, Jain M . The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus. 2011; 9(4):388-93. PMC: 3200407. DOI: 10.2450/2011.0050-10. View

5.
Agrawal A, Hussain K, Kumar A . Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy. Intractable Rare Dis Res. 2020; 9(1):43-47. PMC: 7062592. DOI: 10.5582/irdr.2019.01094. View